Skip to main content
Premium Trial:

Request an Annual Quote

American Cyanamid Signs Gene Product Agreement with Hyseq

Premium

P

ARSIPPANY, NJ--American Cyanamid and Hyseq announced last month that they have entered a multiyear agreement to discover agriculturally relevant genes using Hyseq’s high-throughput genomics and bioinformatics technologies. The deal also calls for the companies to use Hyseq’s proprietary technology to develop products for use in crop protection, crop production, nutraceuticals, human and animal foodstuffs, industrial products, and chemical intermediates, as well as plant-based pharmaceuticals. Under the terms of the agreement, Hyseq will receive $60 million in revenues over a 3.5 year period and future royalty payments for products originating from the collaboration.

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.